Participated · Equity · Oct 2018

LetsMD operates an online marketplace that enables patients to finance elective surgeries by converting bills into equated monthly installments. Operated by Medbay India Pvt. Ltd, the startup currently serves Delhi, Mumbai and Kolkata and plans to expand to Pune and Bengaluru by the end of the year. The company reported it is growing 30% month-on-month. Financially, LetsMD has been in pre-Series A: it raised $1 million in April led by SRI Capital and ThinKuvate and has taken a further $1 million top-up as part of the same pre-Series A, with the pre-Series A totaling Rs 13 crore. The recent infusion included Rs 4 crore of new equity and secondary transactions involving existing backers. LetsMD plans to use the capital to expand operations and strengthen its tech infrastructure as it prepares for larger institutional rounds.

Participated · Series A · May 2018

ImpactGuru is a social-impact crowdfunding platform run by Mumbai-based Impact Guru Technology Ventures Private Limited and incubated at Harvard in 2014. The platform combines donation crowdfunding with investment-style fundraising for individuals, nonprofits, social enterprises and startups. It has an exclusive strategic partnership with GlobalGiving; together they have raised Rs 105 crore ($16M) for social causes in India. The company says healthcare is a major category on its platform and will be the preferred crowdfunding platform for Apollo Hospitals patients nationwide. ImpactGuru recently won the TechCircle Award for best social-impact startup. The company plans to use new capital to ramp up sales and marketing and invest in AI, machine learning, big data, and support for Indian languages.

Participated · Equity · Mar 2018

Wellthy Therapeutics, founded in 2015, offers a mobile app that lets users log meals and monitor blood sugar over time to manage type 2 diabetes. The app is available on Android and iOS and supports multiple Indian languages. The company says it uses clinically validated behavioural interventions to help users change habits and reduce chronic disease risk. For now it solely focuses on diabetes management and cites competitors including Glooko, Holmusk and mySugr. Financially, revenue from operations rose to Rs 89.73 lakh in FY19 from Rs 8.56 lakh in FY18, while total expenditure increased to Rs 9.84 crore and net losses were Rs 8.69 crore. Wellthy Therapeutics develops an AI-based mobile app that acts as a personal health coach for type 2 diabetes patients, using clinical data and habit tracking to deliver motivational, personalized advice. The app lets users log meals, monitor blood sugar over time, track medications, and interact with Carey, the company’s chatbot, and includes gamification such as badges. The company operates on a B2B2C revenue model, working with medical insurers, clinics, and the pharma industry, and plans to build deeper integrations with industry stakeholders in Asia and expand its team. Wellthy will use the fresh proceeds to enhance existing infrastructure and to develop solutions for other disease areas. The startup has endorsements from organizations including the Research Society for Studying Diabetes in India and competes in a similar space to players like CureFit and HealthifyMe. The company was initially self-funded by founder Abhishek Shah (around Rs 2.9 crore) and previously received an undisclosed investment from GrowX Ventures in December 2017.

Participated · Seed · Sep 2017

Founded in 2016, myUpchar provides multilingual health resources that already attract more than 40 million monthly users and have generated 2 billion lifetime views. The platform blends Ayurveda with modern medicine and artificial-intelligence tools to deliver personalized health information and care. Building on this foundation, the company intends to evolve into a full-stack digital hospital, integrating micro-apps that address lifestyle conditions and deploying AI-driven health recommendation systems. Upcoming initiatives also include deeper engagement with tier-1 consumers through wellness offerings. By uniting traditional and modern care modalities in a single digital ecosystem, myUpchar aims to broaden access to quality healthcare across India. The newly raised capital will finance these expansions, although specific financial metrics such as revenue were not disclosed in the article.